Scimitar Equity Research Issues Review of Cambridge Heart, Inc.
18 February 2005 - 12:30AM
PR Newswire (US)
Scimitar Equity Research Issues Review of Cambridge Heart, Inc.
BOSTON, Feb. 17 /PRNewswire/ -- Scimitar Equity Research, Inc.
(Scimitar) issues a review of Cambridge Heart, Inc. (OTC:CAMH)
(BULLETIN BOARD: CAMH) , entitled, "Identifying Patient Risk for
Sudden Cardiac Death." This review is available at our website:
http://www.scimitarequity.com/. Scimitar Equity Research, Inc.
(Scimitar) provides sponsored equity research of the health
sciences industry for the institutional and investment communities.
We certify that all the views expressed in this review accurately
reflect our personal views about CAMH (OTC Bulletin Board) and its
or their securities. No part of our compensation was, is, or will
be, directly or indirectly, related to the specific recommendations
or views contained in this review and we will not have any
investment banking relationships or personal investment in any
sponsored company. Investors are advised that this analysis and
review is issued solely for informational purposes and is not to be
construed as an offer to sell or the solicitation of an offer to
buy. Scimitar was paid for preparing this review. This analysis and
review does not have regard to the specific investment objectives,
financial situation and the information contained herein is based
on sources that we believe to be reliable but is not guaranteed by
us as being accurate and does not purport to be a complete
statement or summary of the available data. Any opinions expressed
are statements of our own judgment as of the date of publication
and are subject to change without notice. Please read all our
important disclosures. DATASOURCE: Scimitar Equity Research, Inc.
CONTACT: Henry W. McCusker, Director of Research of Scimitar Equity
Research, Inc., +1-617-236-6396, Web site:
http://www.scimitarequity.com/
Copyright